Alnylam Pharmaceuticals Inc
NASDAQ:ALNY

Watchlist Manager
Alnylam Pharmaceuticals Inc Logo
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Watchlist
Price: 245.44 USD 2.75% Market Closed
Market Cap: 31.7B USD
Have any thoughts about
Alnylam Pharmaceuticals Inc?
Write Note

Intrinsic Value

The intrinsic value of one ALNY stock under the Base Case scenario is 180.91 USD. Compared to the current market price of 245.44 USD, Alnylam Pharmaceuticals Inc is Overvalued by 26%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALNY Intrinsic Value
180.91 USD
Overvaluation 26%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Alnylam Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
ALNY
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for ALNY cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ALNY?
Bearish
Neutral
Bullish

Fundamental Analysis

245.44 USD
+2.75%
+2.75%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Alnylam Pharmaceuticals Inc
US
Biotechnology
Market Cap
31.6B USD
IPO
May 28, 2004
Employees
1 665
United States of America
Market Cap
31.6B USD
Industry
Biotechnology
IPO
May 28, 2004
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Alnylam Pharmaceuticals Inc

Provide an overview of the primary business activities
of Alnylam Pharmaceuticals Inc.

What unique competitive advantages
does Alnylam Pharmaceuticals Inc hold over its rivals?

What risks and challenges
does Alnylam Pharmaceuticals Inc face in the near future?

Has there been any significant insider trading activity
in Alnylam Pharmaceuticals Inc recently?

Summarize the latest earnings call
of Alnylam Pharmaceuticals Inc.

What significant events have occurred
in Alnylam Pharmaceuticals Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Alnylam Pharmaceuticals Inc.

Provide P/S
for Alnylam Pharmaceuticals Inc.

Provide P/E
for Alnylam Pharmaceuticals Inc.

Provide P/OCF
for Alnylam Pharmaceuticals Inc.

Provide P/FCFE
for Alnylam Pharmaceuticals Inc.

Provide P/B
for Alnylam Pharmaceuticals Inc.

Provide EV/S
for Alnylam Pharmaceuticals Inc.

Provide EV/GP
for Alnylam Pharmaceuticals Inc.

Provide EV/EBITDA
for Alnylam Pharmaceuticals Inc.

Provide EV/EBIT
for Alnylam Pharmaceuticals Inc.

Provide EV/OCF
for Alnylam Pharmaceuticals Inc.

Provide EV/FCFF
for Alnylam Pharmaceuticals Inc.

Provide EV/IC
for Alnylam Pharmaceuticals Inc.

Show me price targets
for Alnylam Pharmaceuticals Inc made by professional analysts.

What are the Revenue projections
for Alnylam Pharmaceuticals Inc?

How accurate were the past Revenue estimates
for Alnylam Pharmaceuticals Inc?

What are the Net Income projections
for Alnylam Pharmaceuticals Inc?

How accurate were the past Net Income estimates
for Alnylam Pharmaceuticals Inc?

What are the EPS projections
for Alnylam Pharmaceuticals Inc?

How accurate were the past EPS estimates
for Alnylam Pharmaceuticals Inc?

What are the EBIT projections
for Alnylam Pharmaceuticals Inc?

How accurate were the past EBIT estimates
for Alnylam Pharmaceuticals Inc?

Compare the revenue forecasts
for Alnylam Pharmaceuticals Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Alnylam Pharmaceuticals Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Alnylam Pharmaceuticals Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Alnylam Pharmaceuticals Inc compared to its peers.

Compare the P/E ratios
of Alnylam Pharmaceuticals Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Alnylam Pharmaceuticals Inc with its peers.

Analyze the financial leverage
of Alnylam Pharmaceuticals Inc compared to its main competitors.

Show all profitability ratios
for Alnylam Pharmaceuticals Inc.

Provide ROE
for Alnylam Pharmaceuticals Inc.

Provide ROA
for Alnylam Pharmaceuticals Inc.

Provide ROIC
for Alnylam Pharmaceuticals Inc.

Provide ROCE
for Alnylam Pharmaceuticals Inc.

Provide Gross Margin
for Alnylam Pharmaceuticals Inc.

Provide Operating Margin
for Alnylam Pharmaceuticals Inc.

Provide Net Margin
for Alnylam Pharmaceuticals Inc.

Provide FCF Margin
for Alnylam Pharmaceuticals Inc.

Show all solvency ratios
for Alnylam Pharmaceuticals Inc.

Provide D/E Ratio
for Alnylam Pharmaceuticals Inc.

Provide D/A Ratio
for Alnylam Pharmaceuticals Inc.

Provide Interest Coverage Ratio
for Alnylam Pharmaceuticals Inc.

Provide Altman Z-Score Ratio
for Alnylam Pharmaceuticals Inc.

Provide Quick Ratio
for Alnylam Pharmaceuticals Inc.

Provide Current Ratio
for Alnylam Pharmaceuticals Inc.

Provide Cash Ratio
for Alnylam Pharmaceuticals Inc.

What is the historical Revenue growth
over the last 5 years for Alnylam Pharmaceuticals Inc?

What is the historical Net Income growth
over the last 5 years for Alnylam Pharmaceuticals Inc?

What is the current Free Cash Flow
of Alnylam Pharmaceuticals Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Alnylam Pharmaceuticals Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alnylam Pharmaceuticals Inc

Current Assets 3.4B
Cash & Short-Term Investments 2.8B
Receivables 353.9m
Other Current Assets 221.3m
Non-Current Assets 849.6m
PP&E 703.4m
Other Non-Current Assets 146.2m
Current Liabilities 1.2B
Accounts Payable 70.8m
Accrued Liabilities 988.3m
Other Current Liabilities 161.5m
Non-Current Liabilities 3B
Long-Term Debt 1B
Other Non-Current Liabilities 1.9B
Efficiency

Earnings Waterfall
Alnylam Pharmaceuticals Inc

Revenue
2.1B USD
Cost of Revenue
-306.4m USD
Gross Profit
1.8B USD
Operating Expenses
-2B USD
Operating Income
-188.1m USD
Other Expenses
-144.1m USD
Net Income
-332.3m USD

Free Cash Flow Analysis
Alnylam Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ALNY Profitability Score
Profitability Due Diligence

Alnylam Pharmaceuticals Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional ROE
ROE is Increasing
40/100
Profitability
Score

Alnylam Pharmaceuticals Inc's profitability score is 40/100. The higher the profitability score, the more profitable the company is.

ALNY Solvency Score
Solvency Due Diligence

Alnylam Pharmaceuticals Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Average Altman Z-Score
Long-Term Solvency
41/100
Solvency
Score

Alnylam Pharmaceuticals Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALNY Price Targets Summary
Alnylam Pharmaceuticals Inc

Wall Street analysts forecast ALNY stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALNY is 308.81 USD with a low forecast of 179.78 USD and a high forecast of 420 USD.

Lowest
Price Target
179.78 USD
27% Downside
Average
Price Target
308.81 USD
26% Upside
Highest
Price Target
420 USD
71% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ALNY?

Click here to dive deeper.

Dividends

Alnylam Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ALNY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ALNY Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

ALNY News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one ALNY stock?

The intrinsic value of one ALNY stock under the Base Case scenario is 180.91 USD.

Is ALNY stock undervalued or overvalued?

Compared to the current market price of 245.44 USD, Alnylam Pharmaceuticals Inc is Overvalued by 26%.

Back to Top